Innovative Molecules Gmbh competitive analysis

Explore patent oppositions filed by Innovative Molecules Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses ThereofAICURISNov 17, 2021

Explore Innovative Molecules Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Aug 5, 2020Aminothiazole Derivatives Useful As Antiviral Agents1

Latest PTAB cases involving Innovative Molecules Gmbh

Discover the latest PTAB cases involving Innovative Molecules Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Innovative Molecules Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INNOVATIVE MOLECULES GMBH11 - -
AICURIS - 1 - -
AICURIS ANTI INFECTIVE CURES - 1 - -
AICURIS ANTI-INFECTIVE CURES AG1 - - -